GemPharmatech

🧠 Day 4 at AD/PD™ 2026! 📍 We're still at Booth 76! Stop by to meet our team. Whether you're exploring mechanistic studies or in vivo drug evaluation for #Alzheimer's, #Parkinson's, or related disorders, let's talk about how we can help move your research forward! #ADPD2026

We invite you to an upcoming webinar with GemPharmatech where we will explore our validated induced mouse models of #asthma, including: • Eosinophil-dominant asthma model • Mixed-type asthma model • Neutrophil-dominant asthma model Register now: buff.ly/0YCAZfV

🦠 In our latest blog, we highlight how GemPharmatech’s #fungal infection platform supports #preclinical drug development! We offer validated murine infection models, including fungal sepsis and invasive pulmonary aspergillosis. 👉 Read the full article: buff.ly/JkGAjwC

Join our upcoming webinar on #Asthma Preclinical Models! #Dupilumab and HDM-induced asthma models primarily target #eosinophilic inflammation. It's time to move beyond and explore whether novel #animalmodels can support new asthma drugs. 🔗 Register now: buff.ly/0YCAZfV

Our team is actively engaging across multiple offline events — sharing insights, building connections, and making a meaningful impact. Thank you to everyone who visited our table! 🌟 Reach out to us at sales@gempharmatech.com— let’s keep the conversation going! #GemPharmatech

#GemPharmatech is headed to the UK for #NextGenBiomed2026! 🚀 🔬 Stop by Booth 29 to chat. 🎤 Catch our presentation on preclinical evaluation of #ADCs. Mar 25, 15:00–15:20 Conference Room 2 – Westminster Let's connect and discuss the future of #biologics development! 🧬

A huge thank you to everyone who joined our recent webinar on model selection and strategic design! 🚀 Here are the top insights from the live Q&A to get you started. 👇 Missed the live session? Catch the full recording here: buff.ly/ojfxMRY #MouseModels #GemPharmatech

🧠 We’re heading to AD/PD™ 2026 in Copenhagen! Meet us at Booth #𝟳𝟲 and see how our integrated #preclinical solutions can support your mechanistic studies for #Alzheimersdisease and #Parkinsonsdisease. Join our two poster presentations: buff.ly/IuBDoVi #ADPD2026

Whether you’re advancing next-generation #HFpEF therapies or optimizing #HFrEF drug candidates, robust translational models are critical to de-risk development and improve clinical predictability. 👉 Read the full blog to explore the complete model panel: buff.ly/DqfMpqY

For years, #weightloss has been the focus of #obesityresearch. But is the scale enough? Fat reduction with lean mass preservation is a far more meaningful therapeutic goal now. 👉 Our comprehensive #metabolic platforms go beyond to support your research: buff.ly/lWD4SUw

GemPharmatech's San Diego CRO facility has officially received full accreditation from #AAALAC International! This accreditation is a reflection of our team’s unwavering commitment to the highest standards of #animalwelfare and scientific excellence. 🔗 buff.ly/P8HILjo

🚨 Last chance to register! Don’t miss tomorrow’s webinar: "From Off-the-Shelf to Purpose-Built: Optimizing Mouse Models for Mechanistic and Translational Research" ⏰ Secure your spot now: buff.ly/W3rbseF #BiomedicalResearch #Knockout #DrugDiscovery #GemPharmatech

Celebrating the Year of the Horse at GemPharmatech! 🎉 Food, festivities, and fantastic colleagues—a perfect way to welcome Lunar New Year together. Grateful for this team and the vibrant culture we build every day. #LunarNewYear #TeamCelebration #GemPharmatech

Dr. Bradley Jiang speaking at the Targeted Therapies Partnering & Licensing Summit Asia! Let's continue conversations around drug resistance mechanisms in #ADCs and in vivo CAR-T evaluation, with a focus on enhancing clinical translatability through validated models.

Still selecting the right #mousemodel for your next study? Join our upcoming webinar to explore how GemPharmatech’s Knockout All Project and end-to-end customization services can accelerate your research from gene targeting to validated in vivo models. 👉 buff.ly/W3rbseF

🚀 GemPharmatech will be attending AD/PD™ 2026! We look forward to discussing how our in vivo drug efficacy evaluation platforms and end-to-end study strategies support mechanistic studies and #preclinical evaluation in #AD, #PD, and related #neurological disorders. #ADPD2026

#Gempharmatech is heading to Tokyo for the Targeted Therapies Partnering & Licensing Summit Asia! At this summit, we will showcase how we support the development of next-generation #oncology therapeutics through robust in vivo models and translational research strategies.

#GemPharmatech accelerates in vivo research with ~30,000 #mousemodels developed. In our upcoming webinar, discover how to quickly access validated models or design fully customized solutions for complex experimental needs. Register now: buff.ly/2OWuGYv #Webinar #biotech

In our recent webinar, we explored how next-generation mouse models are transforming preclinical assessment—helping researchers develop safer and more effective in vivo CAR-T strategies. Thank you to everyone who joined us! #ImmunoOncology #CART #Preclinical #GemPharmatech

Happy Lunar New Year! ✨ The year of the horse symbolizes adventure, perseverance, and collective progress. What better energy to have as we all try to move the field of life science forward? #LunarNewYear #YearOfTheHorse #NewYear2026 #Healthcare #Collaboration #FutureOfHealth